Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 13, 2026, 8:01 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 457–480 of 992 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Insomnia Disorders Clear all

Conditions: Chronic Insomnia, Sleep Deprivation, REM Behavior Disorder, REM Sleep Behavior Disorder, REM Sleep Measurement, Insomnia, Insomnia Related to Specified Disorder, Insomnia Due to Other Mental Disorder, Insomnia Comorbid to Psychiatric Disorder, Insomnia Due to Anxiety and Fear, Insomnia Related to Another Mental Condition, Insomnia Disorders, Idiopathic Hypersomnia, Sleep Disorders, Circadian Rhythm, Post Trauma Nightmares, PTSD - Post Traumatic Stress Disorder, Sleep Quality, Anesthesia, Anxiety, Depression, Mental Health, Alzheimer Disease or Associated Disorder, Parkinsons, Circadian Rhythm, Circadian Dysregulation, PTSD, Post-Traumatic, Post-Traumatic Stress Disorder Complex, Military Combat Stress Reaction, Sleep, Military Activity, Veterans, Shift Work Sleep Disorder, Menopause Related Conditions, Pain, Cancer Pain, Athletes
Interventions: PROSOMNIA Sleep Therapy™ (PSTx), Anesthesia-Induced Sleep Therapy, Diprivan (propofol), Astra-Zeneca, Continuous EEG Monitoring; Procedure · Drug · Device
Lead sponsor: Nyree Penn; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Aventura, Florida

Conditions: Insomnia, Posttraumatic Stress Disorder, Cardiovascular Risk Factor
Interventions: Cognitive Behavior Therapy for Insomnia, Weekly phone contacts; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 40 Years to 59 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: CJD (Creutzfeldt Jakob Disease), Prion Diseases, GSS, FFI, Familial Fatal Insomnia
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Charlestown, Massachusetts

Conditions: Breast Cancer
Interventions: Mindfulness-Based Therapy for Insomnia with Cognitive-Behavioral Symptom Coping Skills; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Prince Frederick, Maryland • Henderson, North Carolina • Laurinburg, North Carolina + 1 more

Conditions: Insomnia
Interventions: Shirodhara Oil Treatment; Procedure
Lead sponsor: Southern California University of Health Sciences; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008
U.S. locations: 1
States / cities: Whittier, California

Conditions: Insomnia
Interventions: Placebo, Rozerem 8mg, Rozerem 8mg in combination with Multi Component Behavior Therapy; Drug · Other
Lead sponsor: University of Arizona; Other
Eligibility: 18 Years to 64 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2010
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Primary Insomnia
Interventions: Portable Biofeedback; Device
Lead sponsor: Helicor; Industry
Eligibility: 18 Years to 55 Years
Enrollment: 132 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Caregivers
Interventions: Just-in-time adaptive intervention (JITAI), Control; Behavioral
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 72 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Posttraumatic Stress Disorder
Interventions: Cognitive Processing Therapy, Hypnosis; Behavioral
Lead sponsor: Center for Trauma Recovery, St Louis; Other
Eligibility: 18 Years and older · Female only
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Insomnia, Rumination
Interventions: Mindfulness-Based Therapy for Insomnia; Behavioral
Lead sponsor: Henry Ford Health System; Other
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Novi, Michigan

Conditions: Poor Quality Sleep, Opiate Addiction
Interventions: Trazodone, Placebo; Drug
Lead sponsor: Butler Hospital; Other
Eligibility: 18 Years to 75 Years
Enrollment: 137 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Transient Insomnia
Interventions: Gabapentin; Drug
Lead sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 1,254 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 35
States / cities: Anaheim, California • Bonita, California • Fallbrook, California + 29 more

Conditions: Autistic Disorder, Insomnia
Interventions: supplemental liquid melatonin, flavored liquid or liquid supplemental melatonin; Drug
Lead sponsor: Vanderbilt University; Other
Eligibility: 4 Years to 10 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2010
U.S. locations: 1
States / cities: Nashville, Tennessee

Conditions: Sleep Disturbance
Interventions: S-Adenosyl Methionine (SAMe), Propyl Gallate, Gamma-Aminobutyric Acid (GABA), L-Theanine, and Magnesium Glycinate; Dietary Supplement
Lead sponsor: Bonafide Health; Industry
Eligibility: 40 Years to 65 Years · Female only
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025
U.S. locations: 1
States / cities: Harrison, New York

Conditions: Jet Lag Type Insomnia
Interventions: Tasimelteon, Placebo; Drug
Lead sponsor: Vanda Pharmaceuticals; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 320 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2018
U.S. locations: 12
States / cities: Little Rock, Arkansas • Alameda, California • San Diego, California + 9 more

Conditions: Insomnia, Sleep Deprivation
Interventions: HIRREM-SOP, NCC; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 22 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Chronic Insomnia
Interventions: Expert Recommendations for Implementing Change bundle of strategies, Brief Behavioral Treatment for Insomnia; Behavioral
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 277,920 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Post-Traumatic Stress Disorders, Stress Disorders, Combat Disorders
Interventions: Cognitive Behavioral Therapy; Behavioral
Lead sponsor: The University of Texas Health Science Center at San Antonio; Other
Eligibility: 18 Years and older
Enrollment: 35 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 3
States / cities: San Antonio, Texas

Conditions: Insomnia
Interventions: Go! to Sleep; Behavioral
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 89 Years
Enrollment: 101 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Insomnia
Interventions: CBTI-CS, Sleep Hygiene, CBTI-CS via Telehealth; Behavioral
Lead sponsor: Dana-Farber Cancer Institute; Other
Eligibility: 18 Years and older
Enrollment: 56 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Insomnia, Spinal Cord Injury, Tetraplegia, Sleep Disorders
Interventions: Ramelteon, Placebo; Drug
Lead sponsor: US Department of Veterans Affairs; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2011
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Insomnia Chronic, Insomnia, Insomnia, Primary, Depression, Depressive Symptoms
Interventions: Cognitive Behavioral Therapy for Insomnia (CBT-I); Behavioral
Lead sponsor: University of Pennsylvania; Other
Eligibility: 21 Years to 60 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Stress Resilience, Systemic Inflammation, General Wellbeing, Sleep Quality, Safety
Interventions: Mycolicibacterium petrae KGA-10 (heat-killed), Placebo (microcrystalline cellulose); Dietary Supplement
Lead sponsor: Kioga Inc.; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 107 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2026
U.S. locations: 1
States / cities: Boulder, Colorado

Conditions: Sleep, Diet Modification
Interventions: Diet Quality; Other
Lead sponsor: University of Chicago; Other
Eligibility: 21 Years to 40 Years
Enrollment: 5 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Chicago, Illinois

Search by objective public record fields.

Evaluating the Efficacy and Safety of PROSOMNIA Sleep Therapy™ in Patients With Sleep Deprivation and Chronic Insomnia

An Evaluation of Insomnia Treatment to Reduce Cardiovascular Risk in Patients With Posttraumatic Stress Disorder

OBSERVE: Biomarkers in Individuals at Risk for Prion Disease

Adaptation and Pilot Testing of a Mindfulness-Based Insomnia and Symptom Management Intervention for Women With Breast Cancer Receiving Treatment in Rural Medically Underserved Areas

Usefulness of Shirodhara for Insomnia

Effects of Ramelteon (8mg) Alone and in Combination With Multi-Component Behavioral Therapy on Sleep and Circadian Phase in Patients With Chronic Insomnia

Safety and Efficacy of an Ambulatory Biofeedback Device for Primary Insomnia

Mobile Technology and Data Analytics to Identify Real-time Predictors of Caregiver Well-Being

Sleep-directed Hypnosis As A Complement To Cognitive Processing Therapy (CPT) In Treating Posttraumatic Stress Disorder (PTSD)

Reduce Emotional Symptoms of Insomnia With SleepTreatment

Insomnia and Drug Relapse Risk

A Trial to Assess Consumer Self-Selection and Use of Gabapentin for Occasional Sleeplessness in an Over-the-Counter Environment

Melatonin for Sleep in Children With Autism

Bonafide Sleep Supplement for Menopausal Women With Sleep Complaints

Evaluating the Effects of Tasimelteon vs. Placebo on Jet Lag Type Insomnia

Study of the Effects of HIRREM-SOP for Insomnia

Enhancing Access to Insomnia (EASI) Care in VA PCMHI Clinics

Psychotherapy Treatment of Deployment-Related PTSD in Primary Care Settings

Effectiveness and Adherence to an Online Sleep Program

CBTI-CS: A Novel Cognitive-Behavioral Treatment for Insomnia in Cancer Survivors

Functional Melatonin Replacement for Sleep Disruptions in Individuals With Tetraplegia

Effects of Insomnia Treatment on Metabolism in Patients With Depression

Oral Supplementation With 1 mg of KGA-10 Daily (a Novel Environmentally-derived Mycolicibacterium) for Stress, Sleep, and Inflammation

Diet and Sleep Monitoring